Appendix: DOCUMENT classification scheme for classifying pharmacists' interventions
| Category | Subcategory | |
|---|---|---|
| Type of drug-related problem | ||
| D | Drug choice | Duplication (D1); Drug interaction (D2); Wrong drug (D3); Wrong dosage form (D4); Other drug selection problem (D0) |
| O | Over/underdose prescribed | Dose too high (O1); Dose too low (O2); Other dose problem (O0) |
| C | Compliance | Taking too little (C1); Taking too much (C2); Intentional drug misuse (C3); Difficulty using dosage form (C4); Other compliance problem (C0) |
| U | Untreated indications | Condition not adequately treated (U1); Preventive therapy required (U2); Other untreated indication problem (U0) |
| M | Monitoring required | Laboratory monitoring (M1); Nonlaboratory monitoring (M3); Other monitoring problem (M0) |
| E | Education or counselling advice | Patient drug information request (E1); Confusion about therapy (E2); Demonstration of device (E3); Disease management or advice (E4); Other education or information problem (E0) |
| N | Non-clinical | Non-clinical (N0) |
| T | Toxicity/adverse effect | Toxicity caused by dose (T1); Toxicity caused by drug interaction (T2); Toxicity evident (T3);Other toxicity/adverse effect problem (T0) |
| Actions to investigate the problem | ||
| Action | Investigation: written material (A1); Investigation: software (A2); Investigation: patient history (A3); Investigation: other (A4); Contacted prescriber (A5); Discussion with patient or carer (A6); Corrected without discussion (A7) | |
| Recommendations to resolve the problem | ||
| Recommendation | Dose change (R1); Drug change (R2); Drug formulation change (R3); Drug brand change (R4); Dose frequency/schedule change (R5); Prescription not dispensed (R6); Other changes to therapy (R7); Refer to prescriber (R8); Refer to hospital (R9); Refer for medication review (R10); Other referral required (R11); Education/counselling session (R12); Written summary of medications (R13); Commence dose administration aid (R14); Other written information (R15); Monitoring: nonlaboratory (R16); Monitoring: laboratory test (R17); No recommendation necessary (R18) | |
| Outcome – acceptance of pharmacist's resolution of the problem | ||
| Outcome | Unknown (O0); Accepted (O1); Partially accepted (O2); Not accepted (O3) | |
| Clinical significance of the problem | ||
| Significance | Nil (S0); Low (S1); Mild (S2); Moderate (S3); High (S4) | |